| Recruiting | COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME Diabetic Macular Edema, DME, Diabetic Macular Edema (DME) | Phase 3 | 2026-02-16 |
| Recruiting | CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME Diabetic Macular Edema, DME, Diabetic Macular Edema (DME) | Phase 3 | 2026-02-09 |
| Active Not Recruiting | A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Effica Wet Age Related Macular Degeneration, wAMD | Phase 3 | 2024-11-27 |
| Active Not Recruiting | A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Effic Wet Age Related Macular Degeneration, wAMD | Phase 3 | 2024-10-22 |
| Completed | Study of EYP-1901 in Patients With Diabetic Macular Edema (DME) Diabetic Macular Edema | Phase 2 | 2024-01-15 |
| Completed | Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR) Nonproliferative Diabetic Retinopathy | Phase 2 | 2022-09-28 |
| Withdrawn | A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Catara Cataract | Phase 3 | 2022-09-01 |
| Withdrawn | A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Catara Cataract | Phase 3 | 2022-09-01 |
| Completed | Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) Wet Age-related Macular Degeneration | Phase 2 | 2022-06-30 |
| Recruiting | Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Catarac Cataract | Phase 4 | 2022-01-04 |
| Terminated | Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert Uveitis, Uveitis, Posterior, Uveitis, Intermediate | Phase 3 | 2021-10-13 |
| Completed | First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macu Wet Age-related Macular Degeneration | Phase 1 | 2021-01-20 |
| Terminated | Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 COVID-19, Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | 2020-10-21 |
| Completed | Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latano Ocular Hypertension, Primary Open Angle Glaucoma | Phase 2 | 2020-06-06 |
| Completed | DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001 Cataract | — | 2019-11-13 |
| Completed | The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Prolifera Nonproliferative Diabetic Retinopathy | Phase 2 | 2017-06-09 |
| Completed | Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis Non-Infectious Uveitis | Phase 3 | 2016-02-23 |
| Completed | Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis Posterior Uveitis, Intermediate Uveitis, Panuveitis | Phase 3 | 2015-06-02 |
| Completed | Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert Non-Infectious Uveitis | Phase 3 | 2013-08-02 |